Investigator Gema Moreno-Bueno receives the AVON Grant for her Her2+ Breast Cancer Study Published on 07/11/2012 In recent years, a number of molecular mechanisms have been described that help understand the different clinical behavior of patients with HER2+ breast cancer in terms of therapeu...
HistoScanning makes detecting up to 95% of prostate cancers possible Published on 16/10/2012 At present, the diagnosis of a suspected prostate cancer is based on digital rectal examination and on the levels of PSA in blood. Whenever either of these two parameters, or both,...
MD Anderson Cancer Center Madrid – Hospiten collaborates with the GEPAC Congress 2012 Published on 17/09/2012 Within the lines of providing support and care for the cancer patient, various specialists and nursing staff from our cancer center in Madrid will take part in talks, activities an...
30% of resectable lung cancers can be operated on using video-assisted thoracoscopy Published on 07/09/2012 Video-assisted thoracoscopy (VAT) is an evolution of traditional surgery using small incisions to insert a video scope, with which to see the inside of the chest cavity on a monito...
Advances in molecular diagnostics allow cancer therapies to be personalized and adapted to the needs of each patient Published on 07/09/2012 Almost 200 international specialists in pathology, molecular biology, medical oncology and surgery are meeting in Madrid at the first congress of its kind held in Europe, whose aim...
T-DM1, the Trojan Horse of HER2 Positive breast cancer. Published on 12/06/2012 In Chicago, from June 1 to 5, the latest annual meeting of the American Society of Clinical Oncology (ASCO) took place, at which there were interesting contributions. Among the mos...
El MD Anderson Cancer Center Madrid – Hospiten conciencia a la población sobre protección solar en El Retiro Published on 09/06/2012 Con el objetivo de concienciar a la población sobre la importancia de protegerse de la radiación solar, el MD Anderson Cancer Center Madrid – Hospiten organizó, este sábado 9 de junio, una ca...
El diagnóstico precoz ayuda a superar el 90% de los cánceres de próstata Published on 08/11/2011 En España, cada año se diagnostican 15.000 nuevos pacientes con cáncer de próstata. Aunque no existe ninguna causa desencadenante de la enfermedad, la edad es el principal facto...
Nuevas líneas de tratamiento en cáncer de próstata permiten destruir el tumor con hospitalizaciones inferiores a las 48 horas Published on 08/11/2011 Técnicas como la crioterapia o la cirugía laparoscópica reducen las consecuencias postoperatorias y permiten destruir los tumores con una mínima estancia que, en la mayoría de l...
Un nuevo estudio demuestra la implicación de la proteína LOXL2 en la metástasis de carcinomas basales de mama Published on 08/11/2011 Los carcinomas basales son un subtipo muy agresivo de tumores de mama, de mal pronóstico, con metástasis viscerales y desarrollo de resistencia a la quimioterapia. En la actuali...